Preprint · OA
via OpenAlex
Gut microbial dysbiosis as a limiting factor in the management of primary and secondary sarcopenia: an Asian Indian perspective
Shinjini Bhattacharya, Rohini Bhadra, Annemie M.W.J. Schols, Sucharita Sambashivaiah
Current Opinion in Clinical Nutrition & Metabolic Care · 2020 · ▲ 9 citations
Abstract
PURPOSE OF REVIEW: The article summarizes recent research advances on the role of gut microbiome in primary and secondary sarcopenia. This article also explores the potential contribution of gut dysbiosis to suboptimal sarcopenia management with special focus on factors contributing to gut dysbiosis among Asian Indians. RECENT FINDINGS: Aging and chronic diseases contribute to gut dysbiosis and intestinal barrier dysfunction allowing enhanced microbial translocation that may negatively affect muscle strength, physical function, and frailty. Gut microbiome of Asian Indians has shown a unique composition that is affected by multiple factors, such as socioeconomic status, poor hygiene, high rate of infection and infestations, antibiotic overuse and transition towards a westernized eating pattern. Current management approach for sarcopenia (exercise and/or protein supplementation) fails to address gut dysbiosis and intestinal barrier dysfunction. Incorporating a prebiotic or probiotic element to the intervention strategy may improve gut dysbiosis, inflammation and muscle function. SUMMARY: Gut dysbiosis and intestinal barrier dysfunction appear to be a significant limitation in sarcopenia management, thus gut centric intervention may be perceived as a (co)intervention strategy to be tested in appropriate clinical trials.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1097/mco.0000000000000688
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Bhattacharya, S., Bhadra, R., Schols, A.M., & Sambashivaiah, S. (2020). Gut microbial dysbiosis as a limiting factor in the management of primary and secondary sarcopenia: an Asian Indian perspective. <em>Current Opinion in Clinical Nutrition & Metabolic Care</em>. https://doi.org/10.1097/mco.0000000000000688
Vancouver
Bhattacharya S, Bhadra R, Schols AM, Sambashivaiah S. Gut microbial dysbiosis as a limiting factor in the management of primary and secondary sarcopenia: an Asian Indian perspective. Current Opinion in Clinical Nutrition & Metabolic Care. 2020. doi:10.1097/mco.0000000000000688.
BibTeX
@unpublished{shinjini2020Gutmic,
title = {Gut microbial dysbiosis as a limiting factor in the management of primary and secondary sarcopenia: an Asian Indian perspective},
author = {Shinjini Bhattacharya and Rohini Bhadra and Annemie M.W.J. Schols and Sucharita Sambashivaiah},
journal = {Current Opinion in Clinical Nutrition & Metabolic Care},
year = {2020},
doi = {10.1097/mco.0000000000000688},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Experientia supplementum 2018
Citation only
Microbiome and Gut Dysbiosis
Endocrinology 2023
Citation only
Aging and Gut Dysbiosis
Endocrinology 2024
Citation only
Aging and Gut Dysbiosis
Research Square 2020
Preprint · CC-BY
Dysbiosis, gut barrier dysfunction and inflammation in dementia: A pilot study
Progress in molecular biology and translational science 2022
Citation only
Gut microbiome dysbiosis in neonatal sepsis
Progress in molecular biology and translational science 2022
Citation only